Axalta Coating Systems (AXTA) downside risk is nearly priced in, underpinned by resilient performance of its core segments and strong execution from the management, UBS analysts said Monday in a research note.
Axalta Coating's stock is almost pricing in the analysts' downside scenario, which assumes sales declining about 9% below their estimate of 2025 sales growth of 1.1%. The analysts are also forecasting $930M in earnings before interest, taxes, depreciation and amortization, or EBITDA, about 18% below their 2025 EBITDA estimate of $1.14B. This leads to an average enterprise value/EBITDA multiple, of about $33 per share, which is 5% above current trading.
Looking ahead to 2025/26, the analysts assume only new wins and 2% declines in auto production versus flat previously. They also sees less downside potential in industrial and refinish volumes following a period of weakening already.
UBS upgraded Axalta Coating to buy from neutral, but decreased their price target on the stock to $40 from $42.
Price: 29.22, Change: -0.51, Percent Change: -1.72
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。